MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.70 (154.72% upside)

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetActions
7/24/2015Cantor FitzgeraldDowngradeBuy -> Hold$4.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Roth CapitalDowngradeBuy -> Sell$5.50 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015WedbushReiterated RatingHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Roth CapitalBoost Price TargetBuy$4.00 -> $5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015WedbushSet Price TargetHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015Cantor FitzgeraldSet Price TargetBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Roth CapitalLower Price TargetBuy$4.30 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2015Cantor FitzgeraldReiterated RatingBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015Roth CapitalSet Price TargetBuy$4.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BTIG ResearchInitiated CoverageBuy$5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Roth CapitalUpgradeNeutral -> Buy$2.30 -> $4.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2014Cantor FitzgeraldUpgradeHold -> Buy$2.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014Roth CapitalBoost Price TargetNeutral$1.30 -> $2.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Cantor FitzgeraldDowngradeBuy -> Hold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Roth CapitalDowngradeBuy -> Neutral$15.00 -> $1.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014RBC CapitalDowngradeOutperform -> Sector Perform$9.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014WedbushReiterated RatingNeutral$10.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014WedbushDowngradeOutperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014Cantor FitzgeraldBoost Price Target$8.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014Leerink SwannBoost Price TargetOutperform$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Leerink SwannBoost Price Target$10.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2013Credit SuisseDowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2013 forward)